Literature DB >> 11243465

Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.

S W Tobin1, M K Brown, K Douville, D C Payne, A Eastman, B A Arrick.   

Abstract

Transforming growth factor beta (TGF-beta) is a multifunctional cytokine capable of regulating diverse cellular processes. In this study we investigated the effect of autocrine TGF-beta signaling on tumor necrosis factor (TNF) alpha-induced cell death. We abrogated the TGF-beta autocrine loop by overexpression of a truncated TGF-beta type II receptor in MCF-7 breast carcinoma cells and found that this generated resistance to TNF-alpha-induced cytotoxicity. To elucidate the molecular basis of the influence of TGF-beta on TNF-alpha-induced cytotoxicity, we evaluated the expression levels or activities of proteins involved in TNF-alpha signal transduction or the regulation of apoptosis in general in TGF-beta-responsive and TGF-beta-nonresponsive MCF-7 cells. We observed no significant difference in the expression of TNF-alpha receptors or the TNF receptor-associated death domain protein. In addition, downstream activation of nuclear factor kappaB by TNF-alpha was not altered in cells that had lost TGF-beta responsiveness. Analysis of members of the Bcl-2 family of apoptosis-regulatory proteins revealed that Bcl-X(L) and Bax expression levels were not changed by disruption of TGF-beta signaling. In contrast, the TGF-beta-nonresponsive cells expressed much higher levels of Bcl-2 protein and mRNA than did cells with an intact TGF-beta autocrine loop. Furthermore, restoration of a TGF-beta signal to MCF-7 cells that had spontaneously acquired resistance to TGF-beta caused a reduction in Bcl-2 protein expression. Taken together, our data indicate that loss of autocrine TGF-beta signaling results in enhanced resistance to TNF-alpha-mediated cell death and that this is likely to be mediated by derepression of Bcl-2 expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243465

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  6 in total

1.  MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-β Mediates the migration and actin dynamics of breast cancer cells.

Authors:  Nadège Fils-Aimé; Meiou Dai; Jimin Guo; Mayada El-Mousawi; Bora Kahramangil; Jean-Charles Neel; Jean-Jacques Lebrun
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

2.  Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.

Authors:  Celine Kretschmer; Anne Conradi; Wolfgang Kemmner; Anja Sterner-Kock
Journal:  Cell Oncol (Dordr)       Date:  2011-04-06       Impact factor: 6.730

Review 3.  Apoptosis: targets in pancreatic cancer.

Authors:  Sabine Westphal; Holger Kalthoff
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

4.  Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance.

Authors:  Tomohiko Sakabe; Hiroyuki Tsuchiya; Keita Kanki; Junya Azumi; Kazue Gonda; Yusuke Mizuta; Daisaku Yamada; Hiroshi Wada; Kohei Shomori; Hiroaki Nagano; Goshi Shiota
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

5.  Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.

Authors:  Zhihong Chen; Yinlin Ge; Natalie Landman; Jing X Kang
Journal:  BMC Cancer       Date:  2002-07-30       Impact factor: 4.430

6.  Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes.

Authors:  Zhihong Chen; Yinlin Ge; Jing X Kang
Journal:  BMC Cell Biol       Date:  2004-04-28       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.